SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies - Quaterly Results

30 Jul 2022 Evaluate
A fair growth of 13.21% in the revenue at Rs. 1549.30 millions was reported in the June 2022 quarter as compared to Rs. 1368.50 millions during year-ago period.The Net proft of the company remain more or less same to Rs. 110.90  millions from Rs. 145.90 millions ,decline by -23.99%.The company reported a degrowth in operating Profit to 196.60 millions from 212.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 1549.30 1368.50 13.21 1549.30 1368.50 13.21 5751.81 5146.23 11.77
Other Income 14.10 19.20 -26.56 14.10 19.20 -26.56 84.29 177.62 -52.54
PBIDT 196.60 212.70 -7.57 196.60 212.70 -7.57 772.50 646.25 19.54
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 127.26 -100.00
PBDT 196.60 212.70 -7.57 196.60 212.70 -7.57 772.50 753.41 2.53
Depreciation 75.70 83.60 -9.45 75.70 83.60 -9.45 325.80 342.80 -4.96
PBT 120.90 129.10 -6.35 120.90 129.10 -6.35 446.70 410.61 8.79
TAX 10.00 -16.80 -159.52 10.00 -16.80 -159.52 -43.16 -132.12 -67.33
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 110.90 145.90 -23.99 110.90 145.90 -23.99 489.86 542.73 -9.74
Equity 133.70 133.67 0.02 133.70 133.67 0.02 133.67 123.42 8.30
PBIDTM(%) 12.69 15.54 -18.36 12.69 15.54 -18.36 13.43 12.56 6.95

Venus Remedies Share Price

1042.35 3.25 (0.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×